pentosidine has been researched along with Atheroma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbé, F; Benabdelhak, I; Bermúdez-López, M; Betriu, À; Colàs-Campàs, L; Farràs, C; Fernández, E; Hernández, C; Hernández, M; Jové, M; Kerkeni, M; Lecube, A; Manuel Valdivielso, J; Martínez-Alonso, M; Miquel, E; Ortega, M; Pamplona, R; Polanco, D; Portero-Otin, M; Purroy, F; Rius, F; Sánchez, E; Sánchez-de-la-Torre, M; Simó, R; Suárez, G; Torres, G; Yeramian, A | 1 |
Ikeda, T; Ito, N; Kurita, H; Maruyama, K; Shimada, A; Shiokawa, Y; Utagawa, A | 1 |
Furfaro, AL; Monacelli, F; Odetti, P; Pronzato, MA; Puzzo, A; Sanguineti, R; Storace, D; Traverso, N | 1 |
3 other study(ies) available for pentosidine and Atheroma
Article | Year |
---|---|
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
Topics: Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Fluorescence; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Optical Imaging; Plaque, Atherosclerotic; Prognosis; Prospective Studies; ROC Curve; Skin | 2019 |
High serum pentosidine in branch atheromatous disease among small vessels occlusion.
Topics: Aged; Aged, 80 and over; Arginine; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Humans; Lysine; Male; Middle Aged; Plaque, Atherosclerotic; Prognosis; Risk Factors; Sensitivity and Specificity | 2019 |
Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Diabetic Angiopathies; Extracellular Matrix; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation Mediators; Interleukin-1alpha; Italy; Lysine; Matrix Metalloproteinase 2; Metalloproteases; Plaque, Atherosclerotic; Risk Factors; Severity of Illness Index; Tissue Inhibitor of Metalloproteinase-3 | 2012 |